文献速递前列腺增生与排尿功能障碍

前列腺剜除术与切除术治疗良性前列腺增生的疗效与安全性:随机对照试验的Meta分析

Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2019-02-28

该Meta分析系统检索至2018年9月1日前的随机对照试验,比较经尿道前列腺剜除术与切除术治疗良性前列腺增生的疗效与安全性。共纳入26项随机对照试验的31篇文献、3283例患者。结果显示剜除术在术后12个月IPSS和Qmax优于切除术,住院时间、血红蛋白损失、血钠下降、输血率及并发症更少,但手术时间更长。

要点

  • 剜除术与切除术在术后1、3、6个月的IPSS、Qmax和QoL差异无显著意义。
  • 术后12个月剜除术的IPSS和Qmax显著优于切除术。
  • 剜除术住院时间、血红蛋白损失、血钠下降、输血率及II、III级和早期并发症优于切除术,但手术时间更长。

核心结论

  • 与切除术相比,剜除术术后疗效和安全性更好,血液学变化和严重并发症更少,但手术时间更长。

研究设计与样本

  • 系统检索截至2018年9月1日的文献,纳入的发表文献均为随机对照试验,共26项随机对照试验的31篇文献、3283例患者。
  • 采用国际前列腺症状评分、最大尿流率和生活质量评估疗效,并评估围手术期数据和术后并发症。
  • 使用Cochrane系统和GRADE系统进行质量评价。

主要发现

  • 剜除术组与切除术组在术后1、3、6个月的国际前列腺症状评分、最大尿流率和生活质量差异无显著意义。
  • 术后12个月,剜除术组的国际前列腺症状评分和最大尿流率显著优于切除术组。
  • 剜除术在住院时间、血红蛋白损失、血钠下降、输血率、II级并发症、III级并发症和早期并发症方面优于切除术。
  • 切除术在手术时间方面表现更好。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study is to compare the efficacy and safety of transurethral enucleation and resection of prostate for treatment of benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: This meta-analysis was conducted through a systematic search before 1 September 2018. All included publications were randomized controlled trials (RCTs). Efficacy was evaluated based on International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax), and quality of life (QoL). Perioperative data and complications postoperatively were also assessed. The quality assessment of included studies and results was performed by using the Cochrane System and GRADE (grading of recommendation assessment, development, and evaluation) System. RESULTS: Thirty-one publications involving 26 RCTs with 3283 patients were assessed in this review. The differences between enucleation and resection in IPSS, Qmax, and QoL at 1, 3, and 6 months postoperative were not significant. At 12 months postoperatively, IPSS and Qmax in the enucleation group were significantly better than those in the resection group. The results also suggested a benefit of enucleation over resection in hospital stay, hemoglobin loss, serum sodium decrease, blood transfusion rate, grade II, grade III complications, and early complications. However, resection exhibited a better operative time. CONCLUSION: Compared with resection, enucleation showed better efficacy and safety postoperatively with less hematological changes and severe complications, except for longer operative time.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Yuan P, Ma D, et al. Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. Prostate Cancer Prostatic Dis. 2019. PMID: 30816336. doi:10.1038/s41391-019-0135-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。